Matrix Metalloproteinase-Responsive Drug Delivery Systems
Bioconjugate Chemistry · 16.08.2023 · 34 (8) · 1349-1365
DOI: 10.1021/acs.bioconjchem.3c00266 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioconjugate Chemistry, online erschienen am 03.08.2023. Verfasst von Chenyun Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Chemical Biology, State Key Laboratory of Systems Medicine for Cancer, Shanghai Universities Collaborative Innovation …. Hauptthemen laut MEDLINE: Matrix Metalloproteinases, Neoplasms. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Shanghai Municipal Education Commission, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Matrix metalloproteinases (MMPs) are a class of endopeptidases that are dependent on zinc and facilitate the degradation of extracellular matrix (ECM) proteins, thereby playing pivotal parts in human physiology and pathology. MMPs regulate normal tissue and cellular functions, including tissue development, remodeling, angiogenesis, bone formation, and wound healing. Several diseases, including cancer, inflammation, cardiovascular diseases, and nervous system disorders, have been linked to dysregulated expression of specific MMP subtypes, which can promote tumor progression, metastasis, and inflammation. Various MMP-responsive drug delivery and release systems have been developed by harnessing cleavage activities and overexpression of MMPs in affected regions. Herein, we review the structure, substrates, and physiological and pathological functions of various MMPs and highlight the strategies for designing MMP-responsive nanoparticles to improve the targeting efficiency, penetration, and protection of therapeutic payloads.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Chemical Biology, State Key Laboratory of Systems Medicine for Cancer, Shanghai Universities Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University Schoo…
ORCID-Profile: Gan Jiang, Xiaoling Gao
Förderung
- National Key Research and Development Program of China
- Shanghai Municipal Education Commission
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Zhang, C., Jiang, G., & Gao, X. (2023). Matrix Metalloproteinase-Responsive Drug Delivery Systems. Bioconjugate Chemistry, 34(8), 1349-1365. https://doi.org/10.1021/acs.bioconjchem.3c00266
Vancouver
Zhang C, Jiang G, Gao X. Matrix Metalloproteinase-Responsive Drug Delivery Systems. Bioconjugate Chemistry. 2023;34(8):1349-1365. doi:10.1021/acs.bioconjchem.3c00266
BibTeX
@article{Zhang2023,
author = {Zhang, Chenyun and Jiang, Gan and Gao, Xiaoling},
title = {Matrix Metalloproteinase-Responsive Drug Delivery Systems},
journal = {Bioconjugate Chemistry},
year = {2023},
volume = {34},
number = {8},
pages = {1349--1365},
doi = {10.1021/acs.bioconjchem.3c00266}
}
EUVIMED